Morphological correlates of MAO A VNTR polymorphism: New evidence from cortical thickness measurement

Behavioural Brain Research

Volumn 211, Issue 1, 2010, Pages 118-124

  Cerasa, Antonio ^a   Cherubini, Andrea ^c   Quattrone, Aldo ^a,b   Gioia, Maria C ^a   Magariello, Angela ^a   Muglia, Maria ^a   Manna, Ida ^a   Assogna, Francesca ^c   Caltagirone, Carlo ^c,d   Spalletta, Gianfranco ^c  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Cortical thickness; Imaging genetics; MAO A VNTR genotype; Orbitofrontal cortex

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CINGULATE GYRUS; COGNITION; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; GRAY MATTER; HEMISPHERE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT; WHITE MATTER;

ADOLESCENT; ADULT; AGED; CEREBRAL CORTEX; GENETIC VARIATION; HUMANS; IMAGING, THREE-DIMENSIONAL; ISOENZYMES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MONOAMINE OXIDASE; ORGAN SIZE; REFERENCE VALUES;

EID: 77952323595     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.03.021     Document Type: Article

References (56)

1. Belsky J., Jonassaint C., Pluess M., Stanton M., Brummett B., Williams R. Vulnerability genes or plasticity genes?. Mol Psychiatry 2009, 14:746-754.
2. Buckholtz J.W., Callicott J.H., Kolachana B., Hariri A.R., Goldberg T.E., Genderson M., et al. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry 2007, 13:313-324.
3. Buckholtz J.W., Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci 2008, 31:120-129.
4. Carlesimo G.A., Caltagirone C., Gainotti G. The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996, 36:378-384.
5. Carrel L., Cottle A.A., Goglin K.C., Willard H.F. A first-generation X-inactivation profile of the human X chromosome. Proc Natl Acad Sci USA 1999, 96:14440-14444.
6. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., et al. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
7. Cerasa A., Gioia M.C., Fera F., Passamonti L., Liguori M., Lanza P., et al. Ventro-lateral prefrontal activity during working memory is modulated by MAO A genetic variation. Brain Res 2008, 1201:114-121.
8. Cerasa A., Gioia M.C., Labate A., Lanza P., Magariello A., Muglia M., et al. MAO A VNTR polymorphism and variation in human morphology: a VBM study. Neuroreport 2008, 19:1107-1110.
9. Cerasa A., Gioia M.C., Labate A., Liguori M., Lanza P., Quattrone A. Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal grey matter volume. Neuroreport 2008, 19:405-408.
10. Cerasa A, Cherubini A, Quattrone A, Gioia MC, Tarantino P, Annesi G, et al. Met158 variant of the COMT genotype is associated with thicker cortex in adult brain. Neuroscience 2010; in press, doi:10.1016/j.neuroscience.2010.02.040.
11. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science 2004, 304:878-880.
12. Cohen J. Statistical power analysis for the behavioral sciences 1998, Lawrence Earlbaum Associates, Hillsdale, NJ. 2nd ed.
13. Dale A.M., Fischi B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9:179-194.
14. Deichmann R., Schwarzbauer C., Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3T. Neuroimage 2004, 21:757-767.
15. Encinas J.M., Vaahtokari A., Enikolopov G. Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci USA 2006, 103:8233-8238.
16. Espeseth T., Westlye L.T., Fjell A.M., Walhovd K.B., Rootwelt H., Reinvang I. Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiol Aging 2008, 9:329-340.
17. Fan J., Fossella J., Sommer T., Wu Y., Posner M.I. Mapping the genetic variation of executive attention onto brain activity. Proc Natl Acad Sci USA 2003, 100:7406-7411.
18. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured clinical interview for DSM-IV axis II personality disorders (SCID-II): clinician version 1997, American Psychiatric Press, Washington.
19. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders (SCID-I): clinician version 1997, American Psychiatric Press, Washington.
20. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000, 97:11050-11055.
21. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: automated labelling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
22. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Segonne F., Salat D.H., et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004, 14:11-22.
23. Foley D.L., Eaves L.J., Wormley B., Silberg J.L., Maes H.H., Kuhn J., et al. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry 2004, 61:738-744.
24. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
25. Fowler J.S., MacGregor R.R., Wolf A.P., Arnett C.D., Dewey S.L., Schlyer D., et al. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science 1987, 235:481-485.
26. Fowler J.S., Alia-Klein N., Kriplani A., Logan J., Williams B., Zhu W., et al. Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol Psychiatry 2007, 62:355-358.
27. Gundlah C., Lu N.Z., Bethea C.L. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 2002, 160:271-282.
28. Hamilton H. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
29. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55.
30. Heaton R.K., Chelune G.J., Talley J.L., Kay G.C., Curtiss G. Wisconsin card sorting test manual 1993, Psychological Assessment Resources, Odessa, FL.
31. Honea R., Verchinski B.A., Pezawas L., Kolachana B.S., Callicott J.H., Mattay V.S., et al. Impact of interacting functional variants in COMT on regional grey matter volume in human brain. Neuroimage 2009, 45:44-51.
32. Hulshoff Pol H.E., Schnack H.G., Posthuma D., Mandl R.C., Baaré W.F., van Oel C., et al. Genetic contributions to human brain morphology and intelligence. J Neurosci 2006, 26:10235-10242.
33. Hutton C., Draganski B., Ashburner J., Weiskopf N. A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 2009, 48:371-380.
34. MacLusky N.J., Naftolin F., Goldman-Rakic P.S. Estrogen formation and binding in the cerebral cortex of the developing rhesus monkey. Proc Natl Acad Sci USA 1986, 83:513-516.
35. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
36. Manuck S.B., Flory J.D., Ferrell R.E., Mann J.J., Muldoon M.F. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity and central nervous system serotonergic responsivity. Psychiatry Res 2000, 95:9-23.
37. Manuck S.B., Flory J.D., Muldoon M.F., Ferrell R.E. Central nervous system serotonergic responsivity and aggressive disposition in men. Physiol Behav 2002, 77:705-709.
38. Meyer-Lindenberg A., Buckholtz J.W., Kolachana B.R., Hariri A., Pezawas L., Blasi G., et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 2006, 103:6269-6274.
39. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
40. Panizzon M.S., Fennema-Notestine C., Eyler L.T., Jernigan T.L., Prom-Wormley E., Neale M., et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex 2009, 19:728-735.
41. Passamonti L., Cerasa A., Gioia M.C., Magariello A., Muglia M., Quattrone A., et al. Genetically dependent modulation of serotonergic inactivation in the human prefrontal cortex. Neuroimage 2008, 40:1264-1273.
42. Passamonti L., Fera F., Magariello A., Cerasa A., Gioia M.C., Muglia M., et al. Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol Psychiatry 2006, 59:334-340.
43. Pennington B.F., Filipek P.A., Lefly D., Chhabildas N., Kennedy D.N., Simon J.H., et al. A twin MRI study of size variations in the human brain. J Cogn Neurosci 2000, 12:223-232.
44. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment. Clinical characterization and outcome. Arch Neurol 1999, 56:303-308.
45. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004, 24:10099-10102.
46. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005, 8:828-834.
47. Pfefferbaum A., Sullivan E.V., Swan G.E., Carmeli D. Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiol Aging 2000, 21:63-74.
48. Sabol S.Z., Hu S., Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998, 103:273-279.
49. Shaw P., Wallace G.L., Addington A., Evans A., Rapoport J., Giedd J.N. Effects of the Val158Met catechol-O-methyltransferase polymorphism on cortical structure in children and adolescents. Mol Psychiatry 2009, 14:348-349.
50. Shih J.C., Chen K. MAO-A and -B gene knock-out mice exhibit distinctly different behaviour. Neurobiology 1999, 7:235-246.
51. Spalletta G., Tomaiuolo F., Di Paola M., Trequattrini A., Bria P., Macaluso E., et al. The neuroanatomy of verbal working memory in schizophrenia: a voxel-based morphometry study. Clin Schizophr Relat Psych 2008, 2:79-87.
52. Spoletini I., Cherubini A., Di Paola M., Banfi G., Rüsch N., Martinotti G., et al. Reduced fronto-temporal connectivity is associated with frontal grey matter density reduction and neuropsychological deficit in schizophrenia. Schizophr Res 2009, 108:57-68.
53. Stroop J.R. Studies of interference in serial verbal reactions. J Exp Psychol 1935, 18:643-662.
54. Voets N.L., Hough M.G., Douaud G., Matthews P.M., James A., Winmill L., et al. Evidence for abnormalities of cortical development in adolescent-onset schizophrenia. Neuroimage 2008, 43:665-675.
55. Williams R.B., Marchuk D.A., Gadde K.M., Barefoot J.C., Grichnik K., Helms M.J., et al. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 2003, 28:533-541.
56. Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 2009; in press, doi:10.1016/j.neuroimage.2009.12.028.